Cite

    Van den Bossche, J., Deben, C., De Pauw, I., Lambrechts, H., Hermans, C., Deschoolmeester, V., Jacobs, J., Specenier, P., Pauwels, P., Vermorken, J. B., Peeters, M., Lardon, F., & Wouters, A. (2019). in vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53. Molecular oncology, 13(5), 1196–1213. http://access.bl.uk/ark:/81055/vdc_100081446629.0x000012